Cargando…
Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
Cancers progress when the immune system fails to identify and eliminate malignant cells. Recognition of this, combined with advances in tumor immunology, has allowed development of therapies that induce effective anti-tumor immune responses. For incompletely-understood reasons, effective responses t...
Autores principales: | Gameiro, Steven F., Ghasemi, Farhad, Barrett, John W., Koropatnick, James, Nichols, Anthony C., Mymryk, Joe S., Maleki Vareki, Saman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169583/ https://www.ncbi.nlm.nih.gov/pubmed/30288365 http://dx.doi.org/10.1080/2162402X.2018.1498439 |
Ejemplares similares
-
HPV-Positive and -Negative Cervical Cancers Are Immunologically Distinct
por: Evans, Andris M., et al.
Publicado: (2022) -
High Level Expression of MHC-II in HPV+ Head and Neck Cancers Suggests that Tumor Epithelial Cells Serve an Important Role as Accessory Antigen Presenting Cells
por: Gameiro, Steven F., et al.
Publicado: (2019) -
The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis
por: Salnikov, Mikhail, et al.
Publicado: (2022) -
A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing
por: Nichols, Anthony C., et al.
Publicado: (2012) -
Reduced MHC Class I and II Expression in HPV−Negative vs. HPV−Positive Cervical Cancers
por: Evans, Andris M., et al.
Publicado: (2022)